MorphoSys Signs Global License Agreement with GSK for Anti-Inflammatory Program

News   Jun 04, 2013

 
MorphoSys Signs Global License Agreement with GSK for Anti-Inflammatory Program
 
 
 

RELATED ARTICLES

Cannabinoids Are Easier on the Brain Than Booze, Study Finds

News

The research was published in the journal Addiction.

READ MORE

Concept Life Sciences Expands GXP Compliance

News

Successful MHRA inspection at Dundee site confirms GLP accreditation for in vitro safety studies and bioanalysis. GLP ensures quality and integrity in non-clinical laboratory studies and gives confidence in safety assessment.

READ MORE


 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE